search

The program will recognize exceptional researchers and innovators who are developing novel ways of making energy cleaner, cheaper, and more reliable and using it more efficiently –  calling worldwide attention to the most promising ideas from across the globe. This program is part of the global initiative Mission Innovation and will contribute to its objectives by fostering cross-border exchanges of ideas and talent, while also raising a greater awareness amongst the wider clean energy community of the transformational potential of energy innovation.

Mission Innovation Champions

Mission Innovation Champions are individuals with a track record of progressing creative new ideas that can drive the pace and scale of the clean energy revolution—the people who are inventing the products and services of the future or discovering the science that underpins them. They may be working in government laboratories, local universities, long-standing research firms, or their own recently launched clean technology start-up companies. Champions may be from “traditional” inventor disciplines such as sciences, engineering, mathematics, and architecture or from other fields.

The Champion for the European Commission will be selected from a European Union country that is not an individual member of Mission Innovation; this means : Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Greece, Hungary, Ireland, Latvia, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovakia, Slovenia, and Spain).

One Champion from each Mission Innovation member participating in the program will be selected. Participating countries include: Australia, Austria, Canada, China, Denmark, European Commission, Finland, France, Germany, India, Italy, Japan, Mexico, Netherlands, Norway, Republic of Korea, Saudi Arabia, Sweden, and the United Arab Emirates.

To learn more and register, visit www.michampions.net.

The registration deadline is 10 September 2018.

 

Read more

Innovative Medicines Initiative: “A human adventure”

07-11-2018

One of Luxembourg’s main hospitals, the Centre Hospitalier de Luxembourg (CHL), is actively taking part in the European project INNODIA that aims to fight type 1 diabetes. The project receives funding from the Innovative Medicines Initiative (IMI), the world’s biggest public-private partnership in the field of life sciences.
Read more

Winter key events for Horizon 2020

07-11-2018

Luxinnovation’s EU Funding team has compiled all important info days, brokerage events, congresses and conferences until the end of 2018. Please take a look at the list and choose the events that are the most interesting for you. For any more questions, please do not hesitate to contact us.
Read more

Funding, network, innovation

31-10-2018

Two more years and ample budgets still remain of Horizon 2020, the EU’s framework programme for research and innovation for the period 2014-2020. Over 80 participants joined Luxinnovation’s Horizon 2020 Day on 25 October to discover the funding opportunities available in 2019 and 2020 and learn more about how to apply for funding and manage Horizon 2020 projects with success.
Read more

EU Battery Alliance: Major progress in establishing battery manufacturing in Europe in only one year

23-10-2018

One year on from the launch of the European Battery Alliance (EBA), the Commission Action Plan is in place, the first pilot production facilities are being built and further projects are announced to establish the EU as the lead player in the strategic area of battery innovation and manufacturing.
Read more

Innovative Medicines Initiative: European recognition of Luxembourg biobanking expertise

22-10-2018

The Integrated Biobank of Luxembourg (IBBL) is participating in two unique European research projects, LITMUS and CANCER-ID, under the umbrella of the Innovative Medicines Initiative (IMI) partnerships.
Read more

All news

Close